Mireia Martínez

Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study

A. Herrera, V. Arrazubi, L. Teijeira, 2022, Frontiers in Pharmacology.

Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events

G. Kochan, V. Arrazubi, D. Escors, 2023, Cancers.

Mathematical models of cytotoxic effects in endpoint tumor cell line assays: critical assessment of the application of a single parametric value as a standard criterion to quantify the dose-response effects and new unexplored proposal formats.

Ricardo C Calhelha, Mireia A Martínez, M A Prieto, 2017, The Analyst.

Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies

S. Domínguez, I. Les, Saioa Eguiluz, 2021, Annals of medicine.

Lung cancer patients with COVID-19 in Spain: GRAVID study

M. Provencio, E. Nadal, M. Dómine, 2021, Lung Cancer.

Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective

B. Ibáñez-Beróiz, Iñaki Elejalde, Mireia Martínez, 2023, Cancers.